The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.
It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy.
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.
There was no upper age limit as data suggested it is likely to have a protective effect in older people.
US military marks 11th successive night of attacks on Iran
Under soaring pressure, India's education minister promises reforms and debate
Rubio says US still willing to negotiate over Iran crisis
Trump says US airlines can now fly to Lebanon for first time since 1985
Bahrain, Kuwait, Jordan face renewed Iranian attacks after US hits Iran's south
